Clinical trial
Study Evaluating Vancomycin-Resistant Enterococci in a Hematology Unit
NCT00167960 · Wyeth is now a wholly owned subsidiary of Pfizer, Industry · Completed
Key facts
| NCT number | NCT00167960 |
|---|---|
| Title | Study Evaluating Vancomycin-Resistant Enterococci in a Hematology Unit |
| Official title | Effects on the Emergence and Transmission of Vancomycin-Resistant Enterococci After Changes in Antibiotic Use in a Hematology Unit. |
| Lead sponsor | Wyeth is now a wholly owned subsidiary of Pfizer, Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Gram-Positive Bacterial Infections |
| Intervention type | Drug |
| Interventions | Piperacillin/tazobactam and other β-lactam/β-lactamase |
| Enrollment | 1,500 |
| Start date | Jan 1, 2005 |
| First posted | Sep 14, 2005 |
| Last update posted | Mar 15, 2007 |
| Countries | South Korea |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: